Differential effects of α-tocopherol and N-acetyl-cysteine on advanced glycation end product-induced oxidative damage and neurite degeneration in SH-SY5Y cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 4, 2012, Pages 550-556

  Pazdro, Robert ^a   Burgess, John R ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Advanced glycation end product; Diabetes; N acetyl cysteine; Neuropathy; Oxidative stress; Vitamin E

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA TOCOPHEROL; GLUTATHIONE;

APOPTOSIS; ARTICLE; CELL DENSITY; CELL LOSS; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; LIPID PEROXIDATION; NERVE CELL DEGENERATION; PRIORITY JOURNAL; PROTEIN CARBONYLATION;

ACETYLCYSTEINE; ALPHA-TOCOPHEROL; CELL LINE; GLUTATHIONE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NEURITES; OXIDATIVE STRESS; SERUM ALBUMIN, BOVINE;

EID: 84856363106     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.01.003     Document Type: Article

References (46)

1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
3. Korshunov S.S., Skulachev V.P., Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997, 416:15-18.
4. Lapolla A., Traldi P., Fedele D. Importance of measuring products of non-enzymatic glycation of proteins. Clin. Biochem. 2005, 38:103-115.
5. Huttunen H.J., Fages C., Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 1999, 274:19919-19924.
6. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 2000, 275:40096-40105.
7. Leclerc E., Fritz G., Weibel M., Heizmann C.W., Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 2007, 282:31317-31331.
8. Goh S.Y., Cooper M.E. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab. 2008, 93:1143-1152.
9. Soulis-Liparota T., Cooper M.E., Dunlop M., Jerums G. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia 1995, 38:387-394.
10. Oldfield M.D., Bach L.A., Forbes J.M., Nikolic-Paterson D., McRobert A., Thallas V., Atkins R.C., Osicka T., Jerums G., Cooper M.E. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products. J. Clin. Invest. 2001, 108:1853-1863.
11. Stitt A.W., Li Y.M., Gardiner T.A., Bucala R., Archer D.B., Vlassara H. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am. J. Pathol. 1997, 150:523-531.
12. Stitt A.W., Bhaduri T., McMullen C.B., Gardiner T.A., Archer D.B. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats. Mol. Cell Biol. Res. Commun. 2000, 3:380-388.
13. Bierhaus A., Haslbeck K.M., Humpert P.M., Liliensiek B., Dehmer T., Morcos M., Sayed A.A., Andrassy M., Schiekofer S., Schneider J.G., Schulz J.B., Heuss D., Neundorfer B., Dierl S., Huber J., Tritschler H., Schmidt A.M., Schwaninger M., Haering H.U., Schleicher E., Kasper M., Stern D.M., Arnold B., Nawroth P.P. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J. Clin. Invest. 2004, 114:1741-1751.
14. Toth C., Rong L.L., Yang C., Martinez J., Song F., Ramji N., Brussee V., Liu W., Durand J., Nguyen M.D., Schmidt A.M., Zochodne D.W. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 2008, 57:1002-1017.
15. Vincent A.M., Perrone L., Sullivan K.A., Backus C., Sastry A.M., Lastoskie C., Feldman E.L. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007, 148:548-558.
16. Nitti M., d'Abramo C., Traverso N., Verzola D., Garibotto G., Poggi A., Odetti P., Cottalasso D., Marinari U.M., Pronzato M.A., Domenicotti C. Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons. Free Radic. Biol. Med. 2005, 38:846-856.
17. Nitti M., Furfaro A.L., Traverso N., Odetti P., Storace D., Cottalasso D., Pronzato M.A., Marinari U.M., Domenicotti C. PKC delta and NADPH oxidase in AGE-induced neuronal death. Neurosci. Lett. 2007, 416:261-265.
18. Lee S.J., Lee K.W. Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells. Biol. Pharm. Bull. 2007, 30:1369-1373.
19. Deuther-Conrad W., Loske C., Schinzel R., Dringen R., Riederer P., Munch G. Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism. Neurosci. Lett. 2001, 312:29-32.
20. Jain S.K., Palmer M. The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic. Biol. Med. 1997, 22:593-596.
21. Selvaraj N., Bobby Z., Sathiyapriya V. Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes. Clin. Chim. Acta 2006, 366:190-195.
22. Wigg S.J., Tare M., Forbes J., Cooper M.E., Thomas M.C., Coleman H.A., Parkington H.C., O'Brien R.C. Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. Diabetologia 2004, 47:1038-1046.
23. Zhang J., Slevin M., Duraisamy Y., Gaffney J., C A.S., Ahmed N. Comparison of protective effects of aspirin, D-penicillamine and vitamin E against high glucose-mediated toxicity in cultured endothelial cells. Biochim. Biophys. Acta 2006, 1762:551-557.
24. Lal M.A., Brismar H., Eklof A.C., Aperia A. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney Int. 2002, 61:2006-2014.
25. Tuttle K.R., Johnson E.C., Cooney S.K., Anderberg R.J., Johnson E.K., Clifton G.D., Meek R.L. Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C. Kidney Int. 2005, 67:953-968.
26. Nagai R., Matsumoto K., Ling X., Suzuki H., Araki T., Horiuchi S. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 2000, 49:1714-1723.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
28. Muller A., Ringseis R., Dusterloh K., Gahler S., Eder K., Steinhart H. Detection of conjugated dienoic fatty acids in human vascular smooth muscle cells treated with conjugated linoleic acid. Biochim. Biophys. Acta 2005, 1737:145-151.
29. Chau K.Y., Ching H.L., Schapira A.H., Cooper J.M. Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis. J. Neurochem. 2009, 110:1005-1013.
30. Pensalfini A., Cecchi C., Zampagni M., Becatti M., Favilli F., Paoli P., Catarzi S., Bagnoli S., Nacmias B., Sorbi S., Liguri G. Protective effect of new S-acylglutathione derivatives against amyloid-induced oxidative stress. Free Radic. Biol. Med. 2008, 44:1624-1636.
31. Vincent A.M., Brownlee M., Russell J.W. Oxidative stress and programmed cell death in diabetic neuropathy. Ann. N. Y. Acad. Sci. 2002, 959:368-383.
32. Gasic-Milenkovic J., Loske C., Deuther-Conrad W., Munch G. Protein "AGEing"-cytotoxicity of a glycated protein increases with its degree of AGE-modification. Z. Gerontol. Geriatr. 2001, 34:457-460.
33. Wei Y., Chen L., Chen J., Ge L., He R.Q. Rapid glycation with d-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells. BMC Cell Biol. 2009, 10:10.
34. Gasic-Milenkovic J., Loske C., Munch G. Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y. J. Alzheimers Dis. 2003, 5:25-30.
35. Zhou B., Wu L.M., Yang L., Liu Z.L. Evidence for alpha-tocopherol regeneration reaction of green tea polyphenols in SDS micelles. Free Radic. Biol. Med. 2005, 38:78-84.
36. Guo Q., Packer L. Ascorbate-dependent recycling of the vitamin E homologue Trolox by dihydrolipoate and glutathione in murine skin homogenates. Free Radic. Biol. Med. 2000, 29:368-374.
37. Aykin-Burns N., Ercal N. Effects of selenocystine on lead-exposed Chinese hamster ovary (CHO) and PC-12 cells. Toxicol. Appl. Pharmacol. 2006, 214:136-143.
38. Reznichenko L., Amit T., Youdim M.B., Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J. Neurochem. 2005, 93:1157-1167.
39. Nakajima M., Kashiwagi K., Hayashi Y., Saito M., Kawashima T., Furukawa S., Kobayashi K. Alpha-tocopherol supports the survival and neurite extension of neurons cultured from various regions of fetal rat brain. Neurosci. Lett. 1991, 133:49-52.
40. Garcia-Alloza M., Dodwell S.A., Meyer-Luehmann M., Hyman B.T., Bacskai B.J. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J. Neuropathol. Exp. Neurol. 2006, 65:1082-1089.
41. Takenouchi T., Hashimoto M., Hsu L.J., Mackowski B., Rockenstein E., Mallory M., Masliah E. Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein. Mol. Cell. Neurosci. 2001, 17:141-150.
42. Huber K., Patel P., Zhang L., Evans H., Westwell A.D., Fischer P.M., Chan S., Martin S. 2-[(1-methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation. Mol. Cancer Ther. 2008, 7:143-151.
43. de Melo Reis R.A., Herculano A.M., da Silva M.C., dos Santos R.M., do Nascimento J.L. In vitro toxicity induced by methylmercury on sympathetic neurons is reverted by l-cysteine or glutathione. Neurosci. Res. 2007, 58:278-284.
44. Volbracht C., Leist M., Nicotera P. ATP controls neuronal apoptosis triggered by microtubule breakdown or potassium deprivation. Mol. Med. 1999, 5:477-489.
45. Nikolaev A., McLaughlin T., O'Leary D.D., Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457:981-989.
46. Duran-Jimenez B., Dobler D., Moffatt S., Rabbani N., Streuli C.H., Thornalley P.J., Tomlinson D.R., Gardiner N.J. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes 2009, 58:2893-2903.